Research/art/teacher profile of a person
- The name of the university:
- Pavol Jozef Šafárik University in Košice
- The seat of the university:
- Šrobárova 2, 041 80 Košice
- The name of the faculty:
- Faculty of Medicine
- The seat of the faculty:
- Trieda SNP 1, 040 01 Košice
I. - Basic information
I.1 - Surname
I.2 - Name
I.3 - Degrees
I.4 - Year of birth
I.5 - Name of the workplace
I.6 - Address of the workplace
I.7 - Position
I.8 - E-mail address
I.9 - Hyperlink to the entry of a person in the Register of university staff
I.10 - Name of the study field in which a person works at the university
I.11 - ORCID iD
II. - Higher education and further qualification growth
II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
II.b - Year
II.c - Study field and programme
II.3 - Third degree of higher education
II.a - Name of the university or institution
II.b - Year
II.c - Study field and programme
II.4 - Associate professor
II.a - Name of the university or institution
II.b - Year
II.c - Study field and programme
II.5 - Professor
II.6 - Doctor of Science (DrSc.)
III. - Current and previous employment
| III.a - Occupation-position | III.b - Institution | III.c - Duration |
|---|---|---|
| doctoral student | P. J. Šafárik University in Košice, Faculty of Science | 1993 - 1997 |
| researcher | Department of Cell Biology, P. J. Šafárik University in Košice, Faculty of Science | 1997 - 2001 |
| assistant professor | Institute of Biology and Ecology, P. J. Šafárik University in Košice, Faculty of Science | 2001 - 2017 |
| visiting scientist | Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA | 2002 - 2003 |
| associated professor | P. J. Šafárik University in Košice, Faculty of Medicine, Department of Medical Biology | 2017 - up to now |
IV. - Development of pedagogical, professional, language, digital and other skills
| IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
|---|---|---|
| Course in digital microscopy and fluorescence techniques in cell biology, Heidelberg, Germany | German Cancer Research Center, Heidelberg | 2000 |
| Training for the performance of activities leading to irradiation, resp. activities important from the point of view of radiation protection, for workers who manage work with sources of ionizing radiation with a focus on the use of open and closed emitters (certificate of professional competence) | Institute of Radiation Protection, Košice | 2006 |
| Summer school of cytometry | European society for clinical cell analysis, Valence, Spain | 2013 |
| Accredited continuing education program: protection of animals used for scientific or educational purposes | 2015 |
V. - Overview of activities within the teaching career at the university
V.1 - Overview of the profile courses taught in the current academic year according to study programmes
| V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
|---|---|---|---|
| Biológia 1, 2 | Všeobecné lekárstvo | I., II. | |
| Biology 1, 2 | General Medicine | I., II. | |
| Medical and human biology 1, 2 | Dental Medicine | I., II. | |
| Lekárska a humánna biológia 1, 2 | Zubné lekárstvo | I., II. |
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
V.4.b - Diploma (second degree)
V.4.c - Dissertation (third degree)
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
V.4.b - Diploma (second degree)
V.4.c - Dissertation (third degree)
V.5 - Overview of other courses taught in the current academic year according to study programmes
| V.5.a - Name of the course | V.5.b - Study programme | V.5.c - Degree | V.5.d - Field of study |
|---|---|---|---|
| Methods in human genetics and molecular biology | General Medicine | I., II. | |
| Biology and genetics | Physiotherapy | I., II. | |
| Medical biology and genetics | Nursing | I., II. |
VI. - Overview of the research/artistic/other outputs
VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
VI.1.b - Over the last six years
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
VI.1.b - Over the last six years
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
VI.1.b - Over the last six years
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
VI.1.b - Over the last six years
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
VI.1.b - Over the last six years
VI.2 - The most significant research/artistic/other outputs
ADC - Solár P., Feldman L., Jeong J.Y., Busingye J.R., Sytkowski A.J., Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype, Int. J. Cancer 122 (2008) 281-288., IF 5.145, Q1. Cited: 29 times
ADC - Jeong J.Y., Feldman L., Solár P., Szenajch J., Sytkowski A.J., Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells, Int. J. Cancer 122 (2008) 274-280.IF 5.145, Q1. Cited: 53 times
ADC- Solár P., Kovaľ J., Mikeš J., Kleban J., Solárová Z., Lazúr J., Hodorová I., Fedoročko P., Sytkowski A.J., Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells, Mol. Cancer Ther. 7 (2008) 2263-2271. IF 5.6, Q1. Cited 23 times
ADC - Ferenc P., Solár P., Kleban J., Mikeš J., Fedoročko P., Down-regulation of Bcl-2 and Akt induced by combination of photoactivated hypericin and genistein in human breast cancer cells. J. Photochem. Photobiol. B. 98 (2010) 25-34. IF 4.4, Q1. Cited: 53 times
ADC - Solár P., Sytkowski A.J., Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780. Cancer Lett. 309 (2011) 11-18. IF 7.4, Q1. Cited: 38 times
VI.3 - The most significant research/artistic/other outputs over the last six years
ADC - Tóthová Z., Tomc J., Debeljak N., Solár P., STAT5 as a Key protein of erythropoietin signalization, Int. J. Mol. Sci. 22 (2021), art. no. 7109. IF=6,208, Q1. Cited: 20 times
ADC - Tóthová Z., Šemeláková M., Solárová Z., Tomc J., Debeljak N., Solár P., The role of PI3K/AKT and MAPK signaling pathways in erythropoietin signalization, Int. J. Mol. Sci. 22, č. 14 (2021), art. no. 7682. IF=6,208, Q1. Cited: 48 times
V3 - Demečková V., Mudroňová D., Gancarčíková S., Kubatka P., Kajo K., Kassayová M., Bojková B., Adamkov M., Solár P., 5-fluorouracil treatment of CT26 colon cancer is compromised by combined therapy with Immodin, Int. J. Mol. Sci. 23 (2022), art. no. 6374. IF=5,6, Q1. Cited: 5 times
V3 - Tóthová Z., Šemeláková M., Bhide K., Bhide M. R., Kováč A., Majerová P., Kvaková M., Štofilová J., Solárová Z., Solár P., Differentially expressed genes induced by erythropoietin receptor overexpression in rat mammary adenocarcinoma RAMA 37-28 cells, Int. J. Mol. Sci. 24 (2023), art. no. 8482. . IF=4,9, Q1. Cited: 0 times
V3 - Bago Pilátová M., Solárová Z., Mezencev R., Solár P., Ceramides and their roles in programmed cell death, Adv. Med. Sci. 68 (2023) 417-425. IF=2,5, Q3. Cited: 11 times
V3 - Mazuráková A., Solárová Z., Lacková L., Čaprnda M., Prosecký R., Khakymov A., Baranenko D., Kubatka P., Mirossay L., Kružliak P., Solár P., Heat shock proteins in cancer - Known but always being rediscovered, Adv. Med. Sci. 6 (2023) 464-473. IF=2,5, Q3. Cited: 3 times
VI.4 - The most significant citations corresponding to the research/artistic/other outputs
ADM- Debeljak N., Solár P., Sytkowski A., Erythropoietin and cancer: the unintended consequences of anemia corrections, Frontiers in Immunology 5 (2014) art. no. 563. IF 5.1, Q1. Citované: 59 krát. ADC: KUHRT, D., WOJCHOWSKI, D.M. Emerging EPO and EPO receptor regulators and signal transducers, Blood, 215, vol. 125, no. 23, s. 3536-3541. IF 17.5, Q1.
ADM- Debeljak N., Solár P., Sytkowski A., Erythropoietin and cancer: the unintended consequences of anemia corrections, Frontiers in Immunology 5 (2014) art. no. 563. IF 5.1, Q1. Citované: 59 krát. ADC - CHATURVEDI, S. et al. Preoperative treatment of anemia and outcomes in surgical Jehovah's Witness patients. In American Journal of Hematology. 94 (2019) E55-E58. IF 7.0, Q1.
ADC - Solár P., Sytkowski A.J., Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780. Cancer Lett. 309 (2011) 11-18. IF 7.4, Q1. Citované: 36 krát ADC - MA, Q. et al. Super-Enhancer Redistribution as a Mechanism of Broad Gene Dysregulation in Repeatedly Drug-Treated Cancer Cells. In Cell Reports, 2020, vol. 31, no. 3, art. no. 107532. IF 8.1, Q1.
ADC - Solár P., Sytkowski A.J., Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780. Cancer Lett. 309 (2011) 11-18. IF 7.4, Q1. Citované: 36 krát ADC - STAFFORD, N. et al. The plasma membrane calcium ATPases and their role as major new players in human disease. In Physiological Reviews, 2017, vol. 97, no. 3, s. 1089-1125. IF 25.6, Q1.
ADM - Uramová S., Kubatka P., Danková Z., Kapinová A., Zoľáková B., Samec M., Žubor P., Zulli A., Valentová V., Kwon T., Solár P., Kello M., Kajo K., Busselberg D., Péč M.-, Danko J., Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach, d 9 (2018) 403-419. IF 4.8, Q1. Citované: 24 krát. ADC - NASIR, A. et al. Nutrigenomics: Epigenetics and cancer prevention: A comprehensive review. In Critical reviews in food science and nutrition, 2020, vol. 60, no. 8, s. 1375-1387. IF 7.9, Q1.
VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
VEGA 1/0394/15: Erythropoietin receptor in mammary adenocarcinoma and its role in tamoxifen resistance, grant project leader.
VEGA 1/0536/19: The role of the erythropoietin receptor in the response of mammary adenocarcinoma cells to paclitaxel in vitro and in vivo, leader of the grant project.
ASFEU project: "Innovation of the technological process of preparation of the immunomodulatory preparation Transfer factor, verification of its effectiveness, safety and composition" (ITMS code 26220220157), leader and project manager.
VEGA 1/0500/23: Erytropoetínový receptor a jeho význam v signalizácii nádorovej bunky
KEGA 024UPJŠ-4/202: Zavedenie praktických kurzov biomedicínskeho výskumu pre doktorandov a integrácia vedeckých pracovníkov do nových výučbových prístupov „PraktikMed"
VII. - Overview of organizational experience related to higher education and research/artistic/other activities
VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study
| VIII.a - Name of the institution | VIII.b - Address of the institution | VIII.c - Duration (indicate the duration of stay) | VIII.d - Mobility scheme, employment contract, other (describe) |
|---|---|---|---|
| Beth Israel Deaconess Medical Center, Harvard Medical School | Boston, MA, USA | 2002 - 2003 | postdoc stay |
| University of Ljubljana | Ljubljana, Slovenia | 1.7.2019 - 6.7.2019 | Erasmus+ |
| Haskoli Islands | Reykjavik, Island | 30.8.2023 - 6.9.2023 | Erasmus+ |